These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 11786903

  • 1. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
    Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM.
    Nat Med; 2002 Jan; 8(1):27-34. PubMed ID: 11786903
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
    Suzuma K, Takagi H, Otani A, Honda Y.
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483
    [Abstract] [Full Text] [Related]

  • 3. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.
    Taverna D, Crowley D, Connolly M, Bronson RT, Hynes RO.
    Cancer Res; 2005 Nov 15; 65(22):10324-9. PubMed ID: 16288021
    [Abstract] [Full Text] [Related]

  • 4. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
    Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM.
    Cancer Res; 2004 Dec 01; 64(23):8643-50. PubMed ID: 15574772
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 6. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL, Jones D, Taylor G, Jaworski K, Kelly DJ, Ludbrook SB, Willette RN, Kumar S, Gilbert RE.
    Invest Ophthalmol Vis Sci; 2006 Apr 01; 47(4):1600-5. PubMed ID: 16565398
    [Abstract] [Full Text] [Related]

  • 7. Integrin indecision.
    Carmeliet P.
    Nat Med; 2002 Jan 01; 8(1):14-6. PubMed ID: 11786895
    [No Abstract] [Full Text] [Related]

  • 8. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.
    Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D.
    Nat Med; 2001 May 01; 7(5):569-74. PubMed ID: 11329058
    [Abstract] [Full Text] [Related]

  • 9. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G.
    J Clin Invest; 2002 Mar 01; 109(6):777-85. PubMed ID: 11901186
    [Abstract] [Full Text] [Related]

  • 10. Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability.
    Robinson SD, Reynolds LE, Wyder L, Hicklin DJ, Hodivala-Dilke KM.
    Arterioscler Thromb Vasc Biol; 2004 Nov 01; 24(11):2108-14. PubMed ID: 15345507
    [Abstract] [Full Text] [Related]

  • 11. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
    Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL.
    Cancer Res; 2000 Feb 01; 60(3):712-21. PubMed ID: 10676658
    [Abstract] [Full Text] [Related]

  • 12. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.
    Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F.
    EMBO J; 1999 Feb 15; 18(4):882-92. PubMed ID: 10022831
    [Abstract] [Full Text] [Related]

  • 13. A mechanism for modulation of cellular responses to VEGF: activation of the integrins.
    Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, Plow EF.
    Mol Cell; 2000 Oct 15; 6(4):851-60. PubMed ID: 11090623
    [Abstract] [Full Text] [Related]

  • 14. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.
    Eliceiri BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, Cheresh DA.
    J Cell Biol; 2002 Apr 01; 157(1):149-60. PubMed ID: 11927607
    [Abstract] [Full Text] [Related]

  • 15. Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin.
    Milner R.
    Glia; 2009 May 01; 57(7):714-23. PubMed ID: 18985734
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC, Malkowski M, Yin Z, Tanghetti E, Yaremko B, Nechuta T, Varner J, Liu M, Smith EM, Neustadt B, Presta M, Armstrong L.
    Cancer Res; 2001 Mar 01; 61(5):2232-8. PubMed ID: 11280792
    [Abstract] [Full Text] [Related]

  • 17. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H.
    Hepatology; 2002 Apr 01; 35(4):834-42. PubMed ID: 11915029
    [Abstract] [Full Text] [Related]

  • 18. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ.
    Angiogenesis; 2008 Apr 01; 11(2):183-90. PubMed ID: 18080776
    [Abstract] [Full Text] [Related]

  • 19. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas.
    Li J, Tan H, Dong X, Xu Z, Shi C, Han X, Jiang H, Krissansen GW, Sun X.
    Dig Liver Dis; 2007 Jun 01; 39(6):557-65. PubMed ID: 17374519
    [Abstract] [Full Text] [Related]

  • 20. Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation.
    Hutchings H, Ortega N, Plouët J.
    FASEB J; 2003 Aug 01; 17(11):1520-2. PubMed ID: 12709411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.